Literature DB >> 6272817

The effect of combination therapy (steroids, immunosuppressives, and plasmapheresis) on 5 mixed cryoglobulinemia patients with renal, neurologic, and vascular involvement.

D Geltner, R W Kohn, P Gorevic, E C Franklin.   

Abstract

A prospective clinical study evaluated the effects of combined chemotherapy, steroids and plasmapheresis on 5 patients with mixed cryoglobulinemia with renal or neurologic and vasculitic manifestations. Treatment included prednisone (1mg/kg/day), chlorambucil (white blood cell count at greater than 3,000/mm3), and plasmapheresis (1 to 3 liters/week). There was healing of cutaneous ulcers (3/3), improvement in renal function (4/4), and diminution of purpura (2/2), but little improvement in peripheral neuropathy. Complications included leukopenia, perineal ulcers, and osteomyelitis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6272817     DOI: 10.1002/art.1780240902

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  7 in total

Review 1.  Role of therapeutic plasmapheresis in ANCA-associated vasculitis.

Authors:  Giles Walters
Journal:  Pediatr Nephrol       Date:  2015-05-19       Impact factor: 3.714

Review 2.  Therapeutic approaches in mixed cryoglobulinemia.

Authors:  D Geltner
Journal:  Springer Semin Immunopathol       Date:  1988

Review 3.  Treatment of vasculitis.

Authors:  H G Taylor; A Samanta
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

4.  Plasmapheresis in clinical medicine.

Authors:  C Linker
Journal:  West J Med       Date:  1983-01

5.  Mutilating cryoglobulinaemia rapidly improved by plasmapheresis: diagnostic features on blood film.

Authors:  M Shaw; J Van de Pette; D Fenton; D H McGibbon
Journal:  J R Soc Med       Date:  1985       Impact factor: 5.344

Review 6.  [Vasculitis associated with viral infections].

Authors:  Pascal Cohen; Loïc Guillevin
Journal:  Presse Med       Date:  2004-11-06       Impact factor: 1.228

Review 7.  Symptomatic cryoglobulinemia.

Authors:  A Dispenzieri
Journal:  Curr Treat Options Oncol       Date:  2000-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.